In mid-October 2013, Evan Kharasch, M.D., Ph.D., was elected to the Institute of Medicine of the National Academy of Sciences. Dr. Kharasch serves as the Vice Chancellor for Research at Washington University in St. Louis. He is also the Director of the Division of Clinical and Translational Research and Russell D. and Mary B. Shelden Professor in the Department of Anesthesiology, in the School of Medicine. Additionally, he holds an appointment as Professor in the Department of Biochemistry and Molecular Biophysics, and in the Washington University Pain Center.

“Kharasch leads the university’s initiative on research innovation and entrepreneurship, which aims to maximize public benefit from the university’s fundamental research discoveries. His office also oversees the continuing education of faculty and staff regarding research regulations as well as issues related to conflict of interest, research integrity, intellectual property and technology transfer. His research interests include basic, translational and clinical pharmacology, with an emphasis on mechanisms and clinical aspects of drug disposition, interactions, toxicity and pharmacogenetics. His studies are aimed toward a better understanding of individual differences in response to drugs and optimization of therapy.”

A full write-up of the honor received by Dr. Kharasch can be found of the Washington University School of Medicine's Department of Anesthesiology website: http://ow.ly/qimyA.

Dr. Kharasch was previously a member of the Clinical Pharmacology, Pharmacogenomics & Translational Medicine Division Executive Committee. He has been a member of ASPET since 1984.